Bleeding and Clotting Disorders Protocol:CSL627_3001 Condition or Disease: Hemophilia A Study Type: Interventional (Clinical Trial) Status: Open for enrollment Study Title: A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII SingleChain, CSL627) in Subjects with Severe Hemophilia A Principal I investigator: Joseph Lasky III,